irinotecan has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bissery, MC; Chabot, GG; Lavelle, F; Vrignaud, P | 1 |
| Andoh, T; Okada, K | 1 |
1 review(s) available for irinotecan and Experimental Leukemia
| Article | Year |
|---|---|
[Mechanisms of acquired resistance to DNA topoisomerase I inhibitors].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Doxorubicin; Drug Resistance; Humans; Irinotecan; Leukemia, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1991 |
1 other study(ies) available for irinotecan and Experimental Leukemia
| Article | Year |
|---|---|
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Irinotecan; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Sensitivity and Specificity; Taxoids; Vincristine | 1996 |